Skip to main content


European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging OnlineFirst articles

22.03.2019 | Short Communication

Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma

False-negativity of 18 fluorine-fluoro-deoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) is an emerging idea in the field of multiple myeloma (MM) diagnosis, which was introduced by Rasche et al. in 2017 [ 1 ]. This …

22.03.2019 | Original Article Open Access

Development and validation of the PET-CT score for diagnosis of malignant pleural effusion

Malignant pleural effusion (MPE) is frequently observed in multiple malignancies, with lung cancer being the most frequent underlying malignancy [ 1 , 2 ]. As the prognosis for patients with MPE is poor [ 3 , 4 ], an efficacious procedure that can …

19.03.2019 | Image of the Month

Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies

16.03.2019 | Original Article

Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy

Prostate cancer (Pca) is the most common malignancy and one of the leading causes of cancer-related death in men worldwide [ 1 ]. Despite advances in Pca therapy, up to 40% of patients develop biochemical recurrence after radical prostatectomy …

16.03.2019 | Letter to the Editor

Grade 3 anaphylactic shock after administration of [99mTc]-labeled nanocolloidal albumin (Nanocoll®) for sentinel node scintigraphy

Aktuelle Ausgaben

Über diese Zeitschrift

Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease. The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.
The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor.

This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members, and also members of the Japanese, Korean and Italian nuclear medicine societies have free access to EJNMMI. As part of this reciprocal agreement, EANM members also have free access to “Annals of Nuclear Medicine”, “Nuclear Medicine and Molecular Imaging” and to “Clinical and Translational Imaging”.

Weitere Informationen